AbbVie closes $200M Nimble Therapeutics acquisition
AbbVie closes $200M Nimble Therapeutics acquisition
STARTS NOW! Rebel Edge 🏴☠️1pm line up: U.S. crude oil prices are dropping due to weak demand from China and expected higher U.S. production after the election. WTI is notably lower, part of a wider commodity slump. Stocks $TSLA $COIN $ABBV $HOOD Sports Detroit's kicker makes 58… https://t.co/mZXNAn84q8 https://t.co/HBCDrov0gz
Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial
M&A deals roundup: AbbVie, Blackstone, Take-Two Interactive and more
AbbVie to buy Aliada Therapeutics for $1.4B in cash
AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s disease
374.36BUSD
Lihat miliarder mana yang memiliki pelaburan ini
taip
Common Stock
Pertukaran
NYSE
Kod matawang
USD
Nama Mata Wang
US Dollar
Nama negara
USA
ISO negara
US
ADALAH DALAM
US00287Y1091
CUSIP
00287Y109
Sektor
Healthcare
industri
Drug Manufacturers - General
Akhir Tahun Fiskal
December
tarikh IPO
-
Dikemaskini Pada
-
Nisbah PE
88.51
Nisbah PEG
0.44
Nilai buku
1.88
Bahagian Dividen
6.29
Hasil Dividen
3.09%
Bahagian Pendapatan
2.39
Harga Sasaran Wall Street
211.05
Anggaran EPS Tahun Semasa
12.28
Anggaran EPS Tahun Depan
13.88
EPS Anggaran Suku Tahun Semasa
2.258
Anggaran EPS Suku Tahun Seterusnya
2.5852
Suku Terkini
-
Hasil TTM
56,334,000,128
Keuntungan Kasar TTM
39,608,999,936
EBITDA
26,208,000,000
Margin keuntungan
7.59%
Pulangan Atas Aset TTM
8.26%
Pulangan Atas Ekuiti TTM
62.29%
Hasil Sesaham TTM
31.845
Pertumbuhan Hasil Qtly YOY
5.60%
Eps TTM yang dicairkan
2.39
Pertumbuhan Pendapatan Qtly YOY
-12.30%
PE mengekori
88.51
PE ke hadapan
17
Harga Jualan TTM
6.6294
Buku Harga MRQ
112.319
Hasil Nilai Perusahaan
7
EBITDA Nilai Perusahaan
29
77.20
1.85%812.00
1.51%43.19
0.77%77.04
0.67%344.01
0.65%109.00
0.00%368.50
-1.60%153.56
-0.58%162.22
-0.48%94.64
-0.07%Senarai pantauan terpilih di mana ABBV dipaparkan.